Results 51 to 60 of about 19,480 (219)
Hepatorenal syndrome in decompensated portal hypertension
Hepatorenal syndrome is the development of kidney failure in patients with decompensated chronic diseases with portal hypertension. This study aimed to search for optimal methods of early diagnostics, therapeutic approaches and establishment of ...
M.I. Tutchenko +5 more
doaj +1 more source
Initial serum sodium concentration determines the decrease in sodium level after terlipressin administration in patients with liver cirrhosis [PDF]
BACKGROUND: Terlipressin, as a prodrug of vasopressin, has agonistic effects on the V1 receptor and partial agonistic effects on renal vasopressin V2 receptors. However, its effects on serum sodium concentration are controversial.
Dae-Hong Jeon +7 more
core +1 more source
Predictors of hepatorenal syndrome in alcoholic liver cirrhosis
Background: Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored.
Martin Janicko +3 more
doaj +1 more source
Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe hepatic encephalopathy [PDF]
There is increasing evidence that terlipressin is useful in patients with cirrhosis and hepatorenal syndrome, but there are no data of its use in patients with acute liver failure (ALF) in whom hepatorenal syndrome is common.
Davies, N.A. +6 more
core
Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study [PDF]
AIM: To investigate clinical and biochemical features of hepatorenal syndrome (HRS), to assess short and long-term survival evaluating potential predictors of early mortality. METHODS: Sixty-two patients with liver cirrhosis and renal failure, defined as
Almasio, P. +6 more
core +1 more source
ABSTRACT This study aimed to assess whether admission plasma lipopolysaccharide‐binding protein (LBP), procalcitonin (PCT), and lactate could improve detection of nosocomial infection in cirrhotic patients presenting with upper gastrointestinal bleeding (UGIB).
Li Chen, Shan‐Shan Dun, Fang Xiao
wiley +1 more source
Background Hepatorenal syndrome is still a diagnosis of exclusion despite new classification. Aims To validate the accuracy of urinary neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1 in the new diagnostic criteria
Mona Abd El-Rahman Abu El-Makarem +4 more
doaj +1 more source
Introduction. Enteral insufficiency syndrome accompanies the development of many acute diseases of the abdominal cavity. According to statistics, as a result of advanced and multi-organ surgery in oncosurgery for 2019–2020, enteral insufficiency was a ...
Oleksii Pavliuchenko +6 more
doaj +1 more source
Liver Transplantation for Budd-Chiari Syndrome [PDF]
Orthotopic liver transplantation was accomplished in a 22-year-old woman dying of the Budd-Chiari syndrome. She is well and has normal liver function 16 months postoperatively.
Porter, KA +4 more
core +1 more source
As the hepatic venous pressure gradient (HVPG) remains the current gold standard for diagnosing portal hypertension in cirrhosis, its clinical application is limited by invasiveness, high cost, and restricted availability. Given the urgent need for noninvasive techniques to dynamically monitor portal vein pressure (PVP), contrast‐enhanced ...
Danping Huang +5 more
wiley +1 more source

